AI-Powered Cancer Vaccines: Oracle's Larry Ellison Unveils 48-Hour Personalized Treatment

AI-Powered Cancer Vaccines Could Be Ready in 48 Hours Says Larry Ellison

Healthcare is moving to new levels enabled by artificial intelligence for early disease detection and treatment. During the White House unveiling of the Stargate Project, Oracle chairman Larry Ellison described a ground-breaking method for tailored cancer vaccines. Al creates these vaccines that can be produced in 48 hours. Larry Ellison talked about how they can use fragments of the tumor in the bloodstream to detect cancer. A simple blood test can determine whether these tiny tumor fragments are present and then verify them with gene sequencing of the tumor. The data from their sequencing is then used to design a personalized vaccine aimed at attacking the specific cancer. This method paves the way for early detection, and fast vaccine development based on cutting-edge AI technology. The Oracle chairman also pointed out the role of robotic systems in manufacturing vaccine. Such systems are designed to help improve the efficiency of production to remove bottlenecks and deliver vaccines to patients promptly.

Oracle's Larry Ellison says AI-driven cancer vaccine could be coming soon as Donald Trump announces a $500 billion investment.

Larry Ellison talked about using AI for cancer vaccine development at a White House meeting. He explained how AI could detect cancer early through blood tests and produce personalized vaccines robotically in 48 hours. Additionally, Oracle, SoftBank, and OpenAI have launched Stargate, a joint venture to develop data centres, creating over 100,000 jobs in the U.S.Oracle Chairman Larry Ellison recently discussed the transformative potential of artificial intelligence (AI) in healthcare during a meeting at the White House, which also featured SoftBank CEO Masayoshi Son and OpenAI CEO Sam Altman. According to Ellison, AI could revolutionize cancer detection, treatment, and vaccine development, offering groundbreaking capabilities. Ellison explained that tiny tumour fragments can circulate in a person's blood, allowing for the possibility of early cancer detection through blood tests. AI could be used to analyze these tests and identify cancer early on. Once the cancerous tumour is gene-sequenced, an individualized vaccine could be created for each patient. Using AI, the mRNA vaccine could be produced robotically in just 48 hours, offering rapid and personalized treatment. Ellison emphasized the incredible potential of AI in advancing cancer care, envisioning a future where early detection, personalized cancer vaccines, and their rapid production could become a reality within just two days. This vision represents the immense promise of AI for the future of medicine. In addition to these advancements, Oracle, SoftBank, and OpenAI have announced a joint venture named Stargate. The venture aims to develop data centres and generate over 100,000 jobs in the United States. The companies and other investors behind Stargate have committed to investing $100 billion in the next four years to support the project. Ellison further revealed that construction of the first data centres for Stargate is already underway in Texas. The project plans to build 20 data centres, each spanning half a million square feet. These facilities could enable AI-powered applications that analyze electronic health records and assist doctors in providing better patient care.

Oracle's Larry Ellison Says Cancer Vaccine Tailored In 48 Hours Could Soon Be A Reality As Trump Announces $500 Billion AI Investment - ARM Holdings (NASDAQ:ARM), Dell Technologies (NYSE:DELL)

Oracle Corp. ORCL co-founder Larry Ellison unveiled plans for an artificial intelligence-driven cancer vaccine system that could deliver personalized treatments within 48 hours, speaking at a White House briefing alongside tech leaders and President Donald Trump on Tuesday. What Happened: The announcement came as part of a broader $500 billion AI infrastructure initiative called Stargate, a joint venture between Oracle, OpenAI, and SoftBank Group. The project will establish massive data centers across the United States, starting with a facility in Abilene, Texas. "We can diagnose cancer using AI through a simple blood test," Ellison explained during the briefing. "Once we sequence the genes of that cancer tumor, we can design an mRNA vaccine for each individual robotically using AI in about 48 hours." The initiative sparked a rally in AI-related stocks, with Oracle shares climbing 7.17% to close at $172.57. Other tech companies also saw significant gains, with NVIDIA Corp. NVDA rising 3.95%, Arm Holdings plc ARM up 8.94%, and Dell Technologies Inc. DELL advancing 4.20%. See Also: Trump's Plan To End $7,500 EV Tax Credits Could Be 'Devastating' For Telsa Rivals, Poll Says Could Be Bullish For Elon Musk's Company Why It Matters: The Stargate venture will initially invest $100 billion in U.S.-based AI infrastructure, with plans to expand to $500 billion over four years. The project includes the construction of ten 500,000-square-foot data centers, with potential expansion to 20 facilities beyond the initial Texas location. During the announcement, Ellison also highlighted AI applications in healthcare, particularly focusing on electronic health records. The system would enable doctors in remote locations to access treatment protocols from leading cancer centers like Memorial Sloan Kettering. The project represents one of the largest private sector investments in AI infrastructure to date, positioning the United States to strengthen its leadership in artificial intelligence technology development. Read Next: Warren Buffett's Pilot Co Exits Global Oil Trading, Refocuses On US Operations: Report Image Via Shutterstock Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. ARMARM Holdings PLC$162.608.94%Overview Rating:Speculative50%Technicals Analysis1000100Financials Analysis200100WatchlistOverviewDELLDell Technologies Inc$114.254.20%NVDANVIDIA Corp$143.153.95%ORCLOracle Corp$180.4412.1%Market News and Data brought to you by Benzinga APIs